All drugs.

Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.

Advertisement

Enter at least 3 characters to search the full directory.

Results

Showing 1–21 of 21 drugs · filtered

AVASTIN (bevacizumab)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY · METASTATIC COLORECTAL CANCER ·+6
GENENTECH

YERVOY (ipilimumab)

ANTINEOPLASTIC-CYTOTOXIC T-LYMP. ANTIGEN (CTLA-4),R-MC ANTIB · METASTATIC MALIGNANT MELANOMA ·+8
BMS PRIMARYCARE

STIVARGA (regorafenib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · METASTATIC COLORECTAL CANCER ·+2
Bayer HealthCare

CYRAMZA (ramucirumab)

VASCULAR ENDOTHELIAL GROWTH FACTOR(VEGF) MONOCLONAL ANTIBODY · METASTATIC COLORECTAL CANCER ·+5
Eli Lilly and Company

OPDIVO (nivolumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · MALIGNANT ESOPHAGEAL NEOPLASM ·+17
BMS PRIMARYCARE

KEYTRUDA (pembrolizumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · MALIGNANT MELANOMA ·+36
Merck Sharp & Dohme

TECENTRIQ (atezolizumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · SMALL CELL LUNG CARCINOMA ·+8
GENENTECH

IMFINZI (durvalumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · BILIARY TRACT MALIGNANCY ·+10
AstraZeneca Pharmaceuticals

IMJUDO (tremelimumab-actl)

ANTINEOPLASTIC-CYTOTOXIC T-LYMP. ANTIGEN (CTLA-4),R-MC ANTIB · LIVER CELL CARCINOMA ·+1
AstraZeneca Pharmaceuticals